RNA sequencing (RNA-seq) has become immensely popular and indispensable in modern biological research. We look at the considerations and challenges of this technology.
Novel solution – duet evoC – distinguishes 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) revealing unprecedented insights into current and future states of disease using one 5ng DNA sample
DNA comprises molecular information stored in genetic and epigenetic bases, both of which are vital to our understanding of biology. The interplay between genetics and the DNA epigenome orchestrates complex biological phenomena as diverse as cell fate, ageing, the response to environmental stimuli, and disease pathogenesis.
A Q&A with Peter Fromen, CEO of biomodal, emphasising the potential applications of their technology, particularly in oncology, liquid biopsy, aging, and neurodegenerative disorders.
Discover how new technology in next generation sequencing can capture the standard A, C, G, T bases plus epigenetic information in a single workflow.
Uncover the role of DNA methylation in Alzheimer’s disease research, from biomarker discovery to therapeutic potential.
John McShane recently joined biomodal as our Director of Business Development for Eastern North America and Canada.
Chad Geringer recently joined biomodal and focuses on business development in North America.
Dr Aziz Mustafa recently joined biomodal as our Director of Sales and Business Development for Europe.
We caught up with Aziz to learn more about him, his background, and what excites him about the field of epigenetics.
Two decades ago the Human Genome Project was completed. Since then, the first sequence of the human genome and subsequent population genomes have provided critical